These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Molecular mechanisms of selective estrogen receptor modulator (SERM) action. Dutertre M; Smith CL J Pharmacol Exp Ther; 2000 Nov; 295(2):431-7. PubMed ID: 11046073 [TBL] [Abstract][Full Text] [Related]
6. Activity of three selective estrogen receptor modulators on hormone-dependent responses in the mouse uterus and mammary gland. Crabtree JS; Peano BJ; Zhang X; Komm BS; Winneker RC; Harris HA Mol Cell Endocrinol; 2008 Jun; 287(1-2):40-6. PubMed ID: 18367319 [TBL] [Abstract][Full Text] [Related]
7. Effects of two novel selective estrogen receptor modulators, raloxifene, tamoxifen, and ethinyl estradiol on the uterus, vagina and breast in ovariectomized cynomolgus monkeys (Macaca fascicularis). Sikoski P; Register TC; Lees CJ; Lundeen S; Hutchison J; Brown KH; Cline JM Am J Obstet Gynecol; 2007 Jan; 196(1):75.e1-7. PubMed ID: 17240242 [TBL] [Abstract][Full Text] [Related]
9. Future perspectives of selective estrogen receptor modulators used alone and in combination with DHEA. Labrie F Endocr Relat Cancer; 2006 Jun; 13(2):335-55. PubMed ID: 16728567 [TBL] [Abstract][Full Text] [Related]
10. Similarity of uterine mucosa changes in patients treated by raloxifen and tamoxifen. Willèn R; Willèn H; Lindahl B Anticancer Res; 2002; 22(2B):1121-5. PubMed ID: 12168910 [TBL] [Abstract][Full Text] [Related]
11. Selective estrogen receptor modulators: an update on recent clinical findings. Shelly W; Draper MW; Krishnan V; Wong M; Jaffe RB Obstet Gynecol Surv; 2008 Mar; 63(3):163-81. PubMed ID: 18279543 [TBL] [Abstract][Full Text] [Related]
12. [Effects of raloxifene on other organs without bone: uterus]. Nozaki M Clin Calcium; 2004 Oct; 14(10):55-60. PubMed ID: 15577132 [TBL] [Abstract][Full Text] [Related]
13. [Lasofoxifene, a next generation estrogen receptor modulator: preclinical studies]. Maeda T; Ke HZ; Simmons H; Thompson D Clin Calcium; 2004 Oct; 14(10):85-93. PubMed ID: 15577137 [TBL] [Abstract][Full Text] [Related]
14. Effects of tamoxifen and raloxifene on normal human endometrial cells in an organotypic in vitro model. Bläuer M; Heinonen PK; Rovio P; Ylikomi T Eur J Pharmacol; 2008 Sep; 592(1-3):13-8. PubMed ID: 18638473 [TBL] [Abstract][Full Text] [Related]
15. Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance. Lewis JS; Jordan VC Mutat Res; 2005 Dec; 591(1-2):247-63. PubMed ID: 16083919 [TBL] [Abstract][Full Text] [Related]
16. Water extract of Er-xian decoction selectively exerts estrogenic activities and interacts with SERMs in estrogen-sensitive tissues. Wong KY; Zhou L; Yu W; Poon CC; Xiao H; Chan CO; Mok DK; Wong MS J Ethnopharmacol; 2021 Jul; 275():114096. PubMed ID: 33823166 [TBL] [Abstract][Full Text] [Related]
17. The effects of the selective estrogen receptor modulators, methyl-piperidino-pyrazole (MPP), and raloxifene in normal and cancerous endometrial cell lines and in the murine uterus. Davis AM; Ellersieck MR; Grimm KM; Rosenfeld CS Mol Reprod Dev; 2006 Aug; 73(8):1034-44. PubMed ID: 16688783 [TBL] [Abstract][Full Text] [Related]
18. Lasofoxifene enhances vaginal mucus formation without causing hypertrophy and increases estrogen receptor beta and androgen receptor in rats. Wang XN; Simmons HA; Salatto CT; Cosgrove PG; Thompson DD Menopause; 2006; 13(4):609-20. PubMed ID: 16837883 [TBL] [Abstract][Full Text] [Related]
19. Raloxifene and its role in breast cancer prevention. Eng-Wong J; Zujewski JA Expert Rev Anticancer Ther; 2004 Aug; 4(4):523-32. PubMed ID: 15270657 [TBL] [Abstract][Full Text] [Related]